Skip to main content

REPLACE: (Riociguat rEplacing PDE5i therapy evaluated Against Continued PDE5i therapy): A Look at Phase IV Study Data

Thank you

This live web event has ended. Thank you for attending.

Contributors

  • Trushil Shah, MD, MSc

    Assistant Professor Of Internal Medicine,
    Associate Director of CTEPH program,
    Pulmonary Hypertension Program,
    UT Southwestern Medical Center

February 7, 2022
Mon 12:00 PM EST

Duration 1H 0M

This live web event has ended.

For Technical Support
(888) 705-6002
+1 (858) 201-4136*
*for callers residing outside of the United States